Long-term safety and tolerability of apremilast in patients with psoriasis : Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)
Crowley, Jeffrey (Bakersfield Dermatology)
Thaçi, Diamant (Universitätsklinikum Schleswig-Holstein (Alemanya))
Joly, Pascal (Department of Dermatology, Hôpital Charles Nicolle, Université de Rouen)
Peris, Ketty (Universitá Cattolica del Sacro Cuore, Roma)
Papp, Kim A. (Probity Medical Research, Waterloo)
Gonçalves, Joana (Celgene Corporation)
Day, Robert M. (Celgene Corporation)
Chen, Rongdean (Celgene Corporation)
Shah, Kamal (Celgene Corporation)
Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Cather, Jennifer C. (Modern Research Associates, Dallas)
Universitat Autònoma de Barcelona
DOI: 10.1016/j.jaad.2017.01.052
The record appears in these collections:
Research literature >
UAB research groups literature >
Research Centres and Groups (research output) >
Health sciences and biosciences >
Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)Articles >
Research articlesArticles >
Published articles
Record created 2018-10-09, last modified 2023-07-06